{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "18",
                "@timestamp": "2023-01-18T05:34:17.000017-05:00",
                "@year": "2023",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "15",
                "@year": "2020",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "American Foundation for AIDS Research"},
                {"xocs:funding-agency-matched-string": "National Health and Medical Research Council of Australia"},
                {
                    "xocs:funding-agency-matched-string": "National Institutes of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "amfAR",
                    "xocs:funding-agency": "amfAR, The Foundation for AIDS Research",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100001117",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck",
                    "xocs:funding-agency": "Merck",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004334",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Gilead Sciences",
                    "xocs:funding-agency": "Gilead Sciences",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005564",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "NHMRC",
                    "xocs:funding-agency-acronym": "NHMRC",
                    "xocs:funding-agency": "National Health and Medical Research Council",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100000925",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2077456/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-12-03T03:46:09.235Z",
            "xocs:funding-text": [
                {"$": "S.R.L. receives research support from National Health and Medical Research Council of Australia (NHMRC), National Institutes of Health (NIH), American Foundation for AIDS Research (amfAR), Gilead Sciences, Merck, and ViiV. She has participated in advisory boards to Merck, Gilead, ViiV, Bionore, Abivax, Calimmune, InniVirVax, and Scientific Advisory Board of the Agence National de Recherche du SIDA. J.S. has received research funding from Gilead Sciences and the NHMRC. A.A. has participated in speaker\u2019s bureau sponsored by Jensen-Cilag. G.V.M. has received research funding from Gilead Sciences and Abbvie. SRL is an NHMRC practitioner fellow and GVM is an NHMRC Career Development Fellow. The remaining authors have no funding or conflicts of interest to disclose."},
                {"$": "support from National Health and Medical Research Council of Australia (NHMRC), National Institutes of Health (NIH), American Foundation for AIDS Research (amfAR), Gilead Sciences, Merck, and ViiV."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Australia",
                            "address-part": "792 Elizabeth Street",
                            "postal-code": "3010",
                            "@afid": "60026553",
                            "@date-locked": "2020-12-16T16:32:18.321",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Peter Doherty Institute for Infection and Immunity"},
                                {"$": "University of Melbourne"},
                                {"$": "Royal Melbourne Hospital"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60026553"},
                                {"@afid": "60001522"},
                                {"@afid": "60012932"},
                                {"@afid": "60117340"},
                                {"@afid": "60019578"},
                                {"@afid": "60026655"},
                                {"@afid": "60008014"},
                                {"@afid": "60005245"}
                            ],
                            "state": "VIC",
                            "ce:source-text": "Peter Doherty Institute for Infection and Immunity, University of Melbourne, 792 Elizabeth Street, Melbourne,Victoria 3010, Australia"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jennifer",
                                "preferred-name": {
                                    "ce:given-name": "Jennifer",
                                    "ce:initials": "J.",
                                    "ce:surname": "Audsley",
                                    "ce:indexed-name": "Audsley J."
                                },
                                "@seq": "1",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Audsley",
                                "@auid": "6508214967",
                                "ce:indexed-name": "Audsley J."
                            },
                            {
                                "ce:given-name": "Sharon R.",
                                "preferred-name": {
                                    "ce:given-name": "Sharon R.",
                                    "ce:initials": "S.R.",
                                    "ce:surname": "Lewin",
                                    "ce:indexed-name": "Lewin S.R."
                                },
                                "@seq": "7",
                                "ce:initials": "S.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD PhD",
                                "ce:surname": "Lewin",
                                "@auid": "15737239300",
                                "ce:indexed-name": "Lewin S.R."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60019578",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Department of Infectious Diseases"},
                                {"$": "Alfred Hospital and Monash University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60019578"},
                                {"@afid": "60008014"}
                            ],
                            "ce:source-text": "Department of Infectious Diseases The Alfred Hospital and Monash University Melbourne Australia"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jennifer",
                                "preferred-name": {
                                    "ce:given-name": "Jennifer",
                                    "ce:initials": "J.",
                                    "ce:surname": "Audsley",
                                    "ce:indexed-name": "Audsley J."
                                },
                                "@seq": "1",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Audsley",
                                "@auid": "6508214967",
                                "ce:indexed-name": "Audsley J."
                            },
                            {
                                "ce:given-name": "Sharon R.",
                                "preferred-name": {
                                    "ce:given-name": "Sharon R.",
                                    "ce:initials": "S.R.",
                                    "ce:surname": "Lewin",
                                    "ce:indexed-name": "Lewin S.R."
                                },
                                "@seq": "7",
                                "ce:initials": "S.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD PhD",
                                "ce:surname": "Lewin",
                                "@auid": "15737239300",
                                "ce:indexed-name": "Lewin S.R."
                            },
                            {
                                "ce:given-name": "Joe",
                                "preferred-name": {
                                    "ce:given-name": "Joe",
                                    "ce:initials": "J.",
                                    "ce:surname": "Sasadeusz",
                                    "ce:indexed-name": "Sasadeusz J."
                                },
                                "@seq": "8",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD PhD",
                                "ce:surname": "Sasadeusz",
                                "@auid": "6701322695",
                                "ce:indexed-name": "Sasadeusz J."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "HIV-NAT"},
                                {"$": "Thai Red Cross AIDS Research"},
                                {"$": "Centre and Tuberculosis Research Unit"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60028190"},
                                {"@afid": "60031780"},
                                {"@afid": "60016965"}
                            ],
                            "ce:source-text": "HIV-NAT Thai Red Cross AIDS Research Centre and Tuberculosis Research Unit Faculty of Medicine Chulalongkorn University Bangkok Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Anchalee",
                            "preferred-name": {
                                "ce:given-name": "Anchalee",
                                "ce:initials": "A.",
                                "ce:surname": "Avihingsanon",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@date-locked": "2023-01-18T05:16:58.450",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Avihingsanon",
                            "@auid": "57196347321",
                            "ce:indexed-name": "Avihingsanon A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60005245",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Victorian Infectious Diseases Reference Laboratory"},
                                {"$": "Royal Melbourne Hospital"},
                                {"$": "Doherty Institute"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60005245"},
                                {"@afid": "60117340"},
                                {"@afid": "60003433"}
                            ],
                            "ce:source-text": "Victorian Infectious Diseases Reference Laboratory Royal Melbourne Hospital at the Doherty Institute Melbourne Australia"
                        },
                        "author": [
                            {
                                "ce:given-name": "Margaret",
                                "preferred-name": {
                                    "ce:given-name": "Margaret",
                                    "ce:initials": "M.",
                                    "ce:surname": "Littlejohn",
                                    "ce:indexed-name": "Littlejohn M."
                                },
                                "@seq": "3",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Littlejohn",
                                "@auid": "16233499900",
                                "ce:indexed-name": "Littlejohn M."
                            },
                            {
                                "ce:given-name": "Scott",
                                "preferred-name": {
                                    "ce:given-name": "Scott",
                                    "ce:initials": "S.",
                                    "ce:surname": "Bowden",
                                    "ce:indexed-name": "Bowden S."
                                },
                                "@seq": "4",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Bowden",
                                "@auid": "56225356200",
                                "ce:indexed-name": "Bowden S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60026655",
                            "@country": "aus",
                            "city": "Sydney",
                            "organization": {"$": "Kirby Institute"},
                            "affiliation-id": {"@afid": "60026655"},
                            "ce:source-text": "The Kirby Institute Sydney Australia"
                        },
                        "author": [{
                            "ce:given-name": "Gail V.",
                            "preferred-name": {
                                "ce:given-name": "Gail V.",
                                "ce:initials": "G.V.",
                                "ce:surname": "Matthews",
                                "ce:indexed-name": "Matthews G.V."
                            },
                            "@seq": "5",
                            "ce:initials": "G.V.",
                            "@date-locked": "2021-10-15T15:54:24.480",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Matthews",
                            "@auid": "7201421490",
                            "ce:indexed-name": "Matthews G.V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60025702",
                            "@country": "aus",
                            "city": "Sydney",
                            "organization": [
                                {"$": "Department of Infectious Diseases"},
                                {"$": "St Vincent's Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60025702",
                                "@dptid": "114092304"
                            },
                            "ce:source-text": "Department of Infectious Diseases St Vincent's Hospital Sydney Australia",
                            "@dptid": "114092304"
                        },
                        "author": [{
                            "ce:given-name": "Gail V.",
                            "preferred-name": {
                                "ce:given-name": "Gail V.",
                                "ce:initials": "G.V.",
                                "ce:surname": "Matthews",
                                "ce:indexed-name": "Matthews G.V."
                            },
                            "@seq": "5",
                            "ce:initials": "G.V.",
                            "@date-locked": "2021-10-15T15:54:24.480",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Matthews",
                            "@auid": "7201421490",
                            "ce:indexed-name": "Matthews G.V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60023619",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Melbourne Sexual Health Centre"},
                                {"$": "Alfred Health"}
                            ],
                            "affiliation-id": {"@afid": "60023619"},
                            "ce:source-text": "Melbourne Sexual Health Centre Alfred Health Melbourne Australia"
                        },
                        "author": [{
                            "ce:given-name": "Christopher K.",
                            "preferred-name": {
                                "ce:given-name": "Christopher K.",
                                "ce:initials": "C.K.",
                                "ce:surname": "Fairley",
                                "ce:indexed-name": "Fairley C.K."
                            },
                            "@seq": "6",
                            "ce:initials": "C.K.",
                            "@date-locked": "2021-03-29T09:50:01.818",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Fairley",
                            "@auid": "55382768300",
                            "ce:indexed-name": "Fairley C.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60012932",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Central Clinical School"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Monash University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60012932"},
                                {"@afid": "60019578"}
                            ],
                            "ce:source-text": "Central Clinical School Faculty of Medicine Monash University Melbourne Australia; and"
                        },
                        "author": [{
                            "ce:given-name": "Christopher K.",
                            "preferred-name": {
                                "ce:given-name": "Christopher K.",
                                "ce:initials": "C.K.",
                                "ce:surname": "Fairley",
                                "ce:indexed-name": "Fairley C.K."
                            },
                            "@seq": "6",
                            "ce:initials": "C.K.",
                            "@date-locked": "2021-03-29T09:50:01.818",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Fairley",
                            "@auid": "55382768300",
                            "ce:indexed-name": "Fairley C.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60005245",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Victorian Infectious Disease Service"},
                                {"$": "Royal Melbourne Hospital"},
                                {"$": "Doherty Institute"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60005245",
                                    "@dptid": "103302856"
                                },
                                {"@afid": "60117340"}
                            ],
                            "ce:source-text": "Victorian Infectious Disease Service Royal Melbourne Hospital at the Doherty Institute Melbourne Australia.",
                            "@dptid": "103302856"
                        },
                        "author": [{
                            "ce:given-name": "Joe",
                            "preferred-name": {
                                "ce:given-name": "Joe",
                                "ce:initials": "J.",
                                "ce:surname": "Sasadeusz",
                                "ce:indexed-name": "Sasadeusz J."
                            },
                            "@seq": "8",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD PhD",
                            "ce:surname": "Sasadeusz",
                            "@auid": "6701322695",
                            "ce:indexed-name": "Sasadeusz J."
                        }]
                    }
                ],
                "citation-title": "Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?",
                "abstracts": "© 2020 Wolters Kluwer Health, Inc.Background:Tenofovir disoproxil fumarate (TDF) is effective in suppressing HIV and hepatitis B virus (HBV) replication in HIV-HBV coinfection although HBV DNA can persist in some individuals on TDF-containing antiretroviral therapy (ART). We initiated a prospective longitudinal study to determine durability of HBV virological control and clinical outcomes after prolonged TDF-based ART in HIV-HBV coinfection.Methods:Ninety-two HIV-HBV coinfected participants on, or about to commence, TDF-containing ART from Australia (n = 41) and Thailand (n = 52) were enrolled. Participants were followed 6-monthly for 2 years, then annually to 5 years. Laboratory and clinical assessments and a serum sample were collected at each study visit. These analyses compare follow-up at 2 and 5 years.Results:12.0% (95% confidence interval 6.8 to 20.2) of total study entry cohort (n = 92) or 15.3% (95% confidence interval: 8.8 to 25.3) of those with data to year 5 (n = 72) lost hepatitis B surface antigen (HBsAg). The only statistically significant association with HBsAg loss was lower study entry quantitative HBsAg. CD4 T-cell count increased by a median 245 cells/mm3 between the preTDF sample and 5 years of follow-up. By year 5, 98.5% of the cohort had undetectable HBV DNA (<15 IU/mL) and 91.4% had undetectable HIV RNA (<20 copies/mL).Conclusions:HBsAg loss was high and ongoing over 5 years of follow-up in HIV-HBV coinfected individuals on TDF-containing ART and undetectable HBV was almost universal. Although the pattern of HBsAg loss temporarily parallels immune reconstitution, we could not identify predictive immune markers. The high rate of HBsAg loss in HIV-HBV coinfection may offer valuable insights into the search for a functional HBV cure.",
                "correspondence": {
                    "affiliation": {
                        "country": "Australia",
                        "address-part": "792 Elizabeth Street",
                        "postal-code": "3010",
                        "@country": "aus",
                        "city": "Melbourne",
                        "organization": [
                            {"$": "Peter Doherty Institute for Infection and Immunity"},
                            {"$": "University of Melbourne"},
                            {"$": "Royal Melbourne Hospital"}
                        ],
                        "state": "VIC",
                        "ce:source-text": "Peter Doherty Institute for Infection and Immunity, University of Melbourne, 792 Elizabeth Street, Melbourne,Victoria 3010, Australia"
                    },
                    "person": {
                        "ce:given-name": "Jennifer",
                        "ce:initials": "J.",
                        "ce:degrees": "PhD",
                        "ce:surname": "Audsley",
                        "ce:indexed-name": "Audsley J."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "HBsAg seroloss",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "HBV",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "HIV",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "long-term ART",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "tenofovir",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://journals.lww.com/jaids/pages/default.aspx",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Acquired Immune Deficiency Syndromes",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "84",
                            "@issue": "5"
                        },
                        "pagerange": {
                            "@first": "527",
                            "@last": "533"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Acquired Immune Deficiency Syndromes",
                    "publicationdate": {
                        "month": "08",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "15 August 2020"
                        },
                        "day": "15"
                    },
                    "codencode": "JJASF",
                    "sourcetitle-abbrev": "J. Acquired Immune Defic. Syndr.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "10779450",
                            "@type": "electronic"
                        },
                        {
                            "$": "15254135",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Lippincott Williams and Wilkins"},
                    "@srcid": "15300154823"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "86.7.4",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNITY TO INFECTION; Medical and Veterinary Virology"
                                },
                                {
                                    "classification-code": "86.7.7",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNITY TO INFECTION; AIDS and HIV"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2725"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": "9000-97-9",
                                    "enzyme-commission-number": "EC 2.6.1.1",
                                    "chemical-name": "aspartate aminotransferase"
                                },
                                {
                                    "cas-registry-number": "9001-60-9",
                                    "enzyme-commission-number": "EC 1.1.1.27",
                                    "chemical-name": "lactate dehydrogenase"
                                },
                                {
                                    "enzyme-commission-number": "EC 1.1.1.27",
                                    "chemical-name": "lactate dehydrogenase A"
                                },
                                {
                                    "cas-registry-number": "202138-50-9",
                                    "chemical-name": "tenofovir disoproxil"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "147127-19-3"},
                                        {"$": "147127-20-6"}
                                    ],
                                    "chemical-name": "tenofovir"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anti-HIV Agents"},
                                {"chemical-name": "DNA, Viral"},
                                {"chemical-name": "Hepatitis B Surface Antigens"},
                                {"chemical-name": "RNA, Viral"},
                                {"chemical-name": "Tenofovir"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "support from National Health and Medical Research Council of Australia (NHMRC), National Institutes of Health (NIH), American Foundation for AIDS Research (amfAR), Gilead Sciences, Merck, and ViiV.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-acronym": "NIH",
                        "grant-agency": "National Institutes of Health"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@timestamp": "BST 03:40:47",
                    "@year": "2020",
                    "@month": "12"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "633336240",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "632415404",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2020397679",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "929457639",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200973992",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32692112",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20202658193",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20203936813",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85088610614",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85088610614",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632415404",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77780299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1097/QAI.0000000000002386"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "42",
                "reference": [
                    {
                        "ref-fulltext": "World Health Organization. Global Hepatitis Report. Geneva, Switzerland: World Health Organization; 2017.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85026783425",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization, Geneva, Switzerland: World Health Organization",
                            "ref-sourcetitle": "Global Hepatitis Report"
                        },
                        "ce:source-text": "World Health Organization. Global Hepatitis Report. Geneva, Switzerland: World Health Organization; 2017."
                    },
                    {
                        "ref-fulltext": "Lincoln D, Petoumenos K, Dore GJ,. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 2003; 4: 241-249.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0042132023",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "241",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Lincoln",
                                    "ce:indexed-name": "Lincoln D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Petoumenos",
                                    "ce:indexed-name": "Petoumenos K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Dore",
                                    "ce:indexed-name": "Dore G.J."
                                }
                            ]},
                            "ref-sourcetitle": "HIV Med."
                        },
                        "ce:source-text": "Lincoln D, Petoumenos K, Dore GJ,. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 2003; 4: 241-249."
                    },
                    {
                        "ref-fulltext": "Ruxrungtham K, Brown T, Phanuphak P,. HIV/AIDS in Asia. Lancet. 2004; 364: 69-82.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "HIV/AIDS in Asia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3042701084",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "364"},
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "82"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Ruxrungtham",
                                    "ce:indexed-name": "Ruxrungtham K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Brown",
                                    "ce:indexed-name": "Brown T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Phanuphak",
                                    "ce:indexed-name": "Phanuphak P."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet."
                        },
                        "ce:source-text": "Ruxrungtham K, Brown T, Phanuphak P,. HIV/AIDS in Asia. Lancet. 2004; 364: 69-82."
                    },
                    {
                        "ref-fulltext": "Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet. 2015; 386: 1546-1555.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84947346338",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "386"},
                                "pagerange": {
                                    "@first": "1546",
                                    "@last": "1555"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Schweitzer",
                                        "ce:indexed-name": "Schweitzer A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Horn",
                                        "ce:indexed-name": "Horn J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mikolajczyk",
                                        "ce:indexed-name": "Mikolajczyk R.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet."
                        },
                        "ce:source-text": "Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet. 2015; 386: 1546-1555."
                    },
                    {
                        "ref-fulltext": "Brook MG, Gilson R, Wilkins EL,. BHIVA Guidelines: Coinfection with HIV and Chronic hepatitis B virus. HIV Med. 2003; 4: 42-51.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "BHIVA Guidelines: Coinfection with HIV and Chronic hepatitis B virus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0142186271",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "42",
                                    "@last": "51"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Brook",
                                    "ce:indexed-name": "Brook M.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Gilson",
                                    "ce:indexed-name": "Gilson R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wilkins",
                                    "ce:indexed-name": "Wilkins E.L."
                                }
                            ]},
                            "ref-sourcetitle": "HIV Med."
                        },
                        "ce:source-text": "Brook MG, Gilson R, Wilkins EL,. BHIVA Guidelines: Coinfection with HIV and Chronic hepatitis B virus. HIV Med. 2003; 4: 42-51."
                    },
                    {
                        "ref-fulltext": "Colin J, Cazals-Hatem D, Loriot M, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999; 29: 1306-1310.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0032953751",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "1306",
                                    "@last": "1310"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Colin",
                                        "ce:indexed-name": "Colin J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cazals-Hatem",
                                        "ce:indexed-name": "Cazals-Hatem D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Loriot",
                                        "ce:indexed-name": "Loriot M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology."
                        },
                        "ce:source-text": "Colin J, Cazals-Hatem D, Loriot M, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999; 29: 1306-1310."
                    },
                    {
                        "ref-fulltext": "Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002; 360: 1921-1926.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037079352",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "360"},
                                "pagerange": {
                                    "@first": "1921",
                                    "@last": "1926"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Thio",
                                        "ce:indexed-name": "Thio C.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Seaberg",
                                        "ce:indexed-name": "Seaberg E.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Skolasky",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Skolasky R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet."
                        },
                        "ce:source-text": "Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002; 360: 1921-1926."
                    },
                    {
                        "ref-fulltext": "Singh KP, Crane M, Audsley J, et al. HIV-hepatitis B virus coinfection: Epidemiology, pathogenesis, and treatment. AIDS. 2017; 31: 2035-2052.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "HIV-hepatitis B virus coinfection: Epidemiology, pathogenesis, and treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85021967294",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "2035",
                                    "@last": "2052"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Singh",
                                        "ce:indexed-name": "Singh K.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Crane",
                                        "ce:indexed-name": "Crane M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Audsley",
                                        "ce:indexed-name": "Audsley J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Singh KP, Crane M, Audsley J, et al. HIV-hepatitis B virus coinfection: Epidemiology, pathogenesis, and treatment. AIDS. 2017; 31: 2035-2052."
                    },
                    {
                        "ref-fulltext": "Audsley J, Arrifin N, Yuen L, et al. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV Med. 2009; 10: 229-235.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "62749093745",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "229",
                                    "@last": "235"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Audsley",
                                        "ce:indexed-name": "Audsley J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Arrifin",
                                        "ce:indexed-name": "Arrifin N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "HIV Med."
                        },
                        "ce:source-text": "Audsley J, Arrifin N, Yuen L, et al. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV Med. 2009; 10: 229-235."
                    },
                    {
                        "ref-fulltext": "de Vries-Sluijs TE, Reijnders JG, Hansen BE, et al. Long-Term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology. 2010; 139: 1934-1941.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Long-Term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78649711070",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "1934",
                                    "@last": "1941"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.E.",
                                        "@_fa": "true",
                                        "ce:surname": "De Vries-Sluijs",
                                        "ce:indexed-name": "De Vries-Sluijs T.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Reijnders",
                                        "ce:indexed-name": "Reijnders J.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hansen",
                                        "ce:indexed-name": "Hansen B.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology."
                        },
                        "ce:source-text": "de Vries-Sluijs TE, Reijnders JG, Hansen BE, et al. Long-Term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology. 2010; 139: 1934-1941."
                    },
                    {
                        "ref-fulltext": "Dore GJ, Cooper DA, Pozniak AL, et al. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and-experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis. 2004; 189: 1185-1192.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "1842607685",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "189"},
                                "pagerange": {
                                    "@first": "1185",
                                    "@last": "1192"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Dore",
                                        "ce:indexed-name": "Dore G.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cooper",
                                        "ce:indexed-name": "Cooper D.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Pozniak",
                                        "ce:indexed-name": "Pozniak A.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis."
                        },
                        "ce:source-text": "Dore GJ, Cooper DA, Pozniak AL, et al. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and-experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis. 2004; 189: 1185-1192."
                    },
                    {
                        "ref-fulltext": "Matthews G, Seaberg E, Avihingsanon A, et al. Patterns and causes of suboptimal response to tenofovir based therapy in HIV-HBV infected individuals. Clin Infect Dis. 2013; 56: E87-94.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Patterns and causes of suboptimal response to tenofovir based therapy in HIV-HBV infected individuals"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876000229",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "56"},
                                "pagerange": {
                                    "@first": "87",
                                    "@last": "94"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Matthews",
                                        "ce:indexed-name": "Matthews G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Seaberg",
                                        "ce:indexed-name": "Seaberg E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis."
                        },
                        "ce:source-text": "Matthews G, Seaberg E, Avihingsanon A, et al. Patterns and causes of suboptimal response to tenofovir based therapy in HIV-HBV infected individuals. Clin Infect Dis. 2013; 56: E87-94."
                    },
                    {
                        "ref-fulltext": "Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers 2018; 4: 18035.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85069180552",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "18035"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen M.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen D.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Dusheiko",
                                        "ce:indexed-name": "Dusheiko G.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Dis Primers"
                        },
                        "ce:source-text": "Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers 2018; 4: 18035."
                    },
                    {
                        "ref-fulltext": "Kim G-A, Lim Y-S, An J, et al. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: Clinical outcomes and durability. Gut 2014; 63: 1325-1332.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: Clinical outcomes and durability"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84904042319",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "1325",
                                    "@last": "1332"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.-A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim G.-A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.-S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim Y.-S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "An",
                                        "ce:indexed-name": "An J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Kim G-A, Lim Y-S, An J, et al. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: Clinical outcomes and durability. Gut 2014; 63: 1325-1332."
                    },
                    {
                        "ref-fulltext": "Papatheodoridis GV, Chan HL, Hansen BE, et al. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy. J Hepatol. 2015; 62: 956-967.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84926407117",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "956",
                                    "@last": "967"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Papatheodoridis",
                                        "ce:indexed-name": "Papatheodoridis G.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan H.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hansen",
                                        "ce:indexed-name": "Hansen B.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol."
                        },
                        "ce:source-text": "Papatheodoridis GV, Chan HL, Hansen BE, et al. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy. J Hepatol. 2015; 62: 956-967."
                    },
                    {
                        "ref-fulltext": "Hamers RL, Zaaijer HL, Wallis CL, et al. HIV-HBV coinfection in Southern Africa and the effect of lamivudine-versus tenofovir-containing cART on HBV outcomes. JAIDS. 2013; 64: 174-182.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "HIV-HBV coinfection in Southern Africa and the effect of lamivudine-versus tenofovir-containing cART on HBV outcomes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84885295369",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "174",
                                    "@last": "182"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hamers",
                                        "ce:indexed-name": "Hamers R.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Zaaijer",
                                        "ce:indexed-name": "Zaaijer H.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wallis",
                                        "ce:indexed-name": "Wallis C.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAIDS."
                        },
                        "ce:source-text": "Hamers RL, Zaaijer HL, Wallis CL, et al. HIV-HBV coinfection in Southern Africa and the effect of lamivudine-versus tenofovir-containing cART on HBV outcomes. JAIDS. 2013; 64: 174-182."
                    },
                    {
                        "ref-fulltext": "Matthews GV, Ali RJ, Avihingsanon A, et al. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS One. 2013; 8: E61297.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876017643",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "61297"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Matthews",
                                        "ce:indexed-name": "Matthews G.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ali",
                                        "ce:indexed-name": "Ali R.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One."
                        },
                        "ce:source-text": "Matthews GV, Ali RJ, Avihingsanon A, et al. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS One. 2013; 8: E61297."
                    },
                    {
                        "ref-fulltext": "Lok AS, Trinh H, Carosi G, et al. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. Gastroenterology. 2012; 143: 619-628.e611.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865490229",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "619",
                                    "@last": "628e611"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lok",
                                        "ce:indexed-name": "Lok A.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Trinh",
                                        "ce:indexed-name": "Trinh H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Carosi",
                                        "ce:indexed-name": "Carosi G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology."
                        },
                        "ce:source-text": "Lok AS, Trinh H, Carosi G, et al. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. Gastroenterology. 2012; 143: 619-628.e611."
                    },
                    {
                        "ref-fulltext": "Audsley J, Bent SJ, Littlejohn M, et al. Effects of long-Term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity. AIDS. 2016; 30: 1597-1606.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Effects of long-Term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960156648",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "1597",
                                    "@last": "1606"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Audsley",
                                        "ce:indexed-name": "Audsley J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bent",
                                        "ce:indexed-name": "Bent S.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Littlejohn",
                                        "ce:indexed-name": "Littlejohn M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Audsley J, Bent SJ, Littlejohn M, et al. Effects of long-Term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity. AIDS. 2016; 30: 1597-1606."
                    },
                    {
                        "ref-fulltext": "Sozzi V, Walsh R, Littlejohn M, et al. In Vitro studies show that sequence variability contributes to marked variation in hepatitis B virus replication, protein expression, and function observed across genotypes. J Virol. 2016; 90: 10054-10064.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "In Vitro studies show that sequence variability contributes to marked variation in hepatitis B virus replication, protein expression, and function observed across genotypes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84995403713",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "90"},
                                "pagerange": {
                                    "@first": "10054",
                                    "@last": "10064"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Sozzi",
                                        "ce:indexed-name": "Sozzi V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Walsh",
                                        "ce:indexed-name": "Walsh R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Littlejohn",
                                        "ce:indexed-name": "Littlejohn M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Virol."
                        },
                        "ce:source-text": "Sozzi V, Walsh R, Littlejohn M, et al. In Vitro studies show that sequence variability contributes to marked variation in hepatitis B virus replication, protein expression, and function observed across genotypes. J Virol. 2016; 90: 10054-10064."
                    },
                    {
                        "ref-fulltext": "Marcellin P, Buti M, Krastev Z, et al. Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. J Hepatol. 2014; 61: 1228-1237.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84922789624",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "1228",
                                    "@last": "1237"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Marcellin",
                                        "ce:indexed-name": "Marcellin P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Buti",
                                        "ce:indexed-name": "Buti M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Krastev",
                                        "ce:indexed-name": "Krastev Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol."
                        },
                        "ce:source-text": "Marcellin P, Buti M, Krastev Z, et al. Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. J Hepatol. 2014; 61: 1228-1237."
                    },
                    {
                        "ref-fulltext": "Boyd A, Gozlan J, Miailhes P, et al. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-Term follow-up of patients coinfected with HIV and hepatitis B virus. AIDS. 2015; 29: 1963-1973.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-Term follow-up of patients coinfected with HIV and hepatitis B virus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84965047969",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "1963",
                                    "@last": "1973"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Boyd",
                                        "ce:indexed-name": "Boyd A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gozlan",
                                        "ce:indexed-name": "Gozlan J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Miailhes",
                                        "ce:indexed-name": "Miailhes P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Boyd A, Gozlan J, Miailhes P, et al. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-Term follow-up of patients coinfected with HIV and hepatitis B virus. AIDS. 2015; 29: 1963-1973."
                    },
                    {
                        "ref-fulltext": "Boyd A, Maylin S, Moh R, et al. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa. J Gastroenterol Hepatol. 2016; 31: 634-644.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959174916",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "634",
                                    "@last": "644"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Boyd",
                                        "ce:indexed-name": "Boyd A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Maylin",
                                        "ce:indexed-name": "Maylin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Moh",
                                        "ce:indexed-name": "Moh R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol."
                        },
                        "ce:source-text": "Boyd A, Maylin S, Moh R, et al. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa. J Gastroenterol Hepatol. 2016; 31: 634-644."
                    },
                    {
                        "ref-fulltext": "Huang AJ, Núñez M,. Outcomes in HIV/HBV-coinfected patients in the tenofovir era are greatly affected by immune suppression. JIAPAC. 2015; 14: 360-368.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Outcomes in HIV/HBV-coinfected patients in the tenofovir era are greatly affected by immune suppression"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84937711175",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "360",
                                    "@last": "368"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang A.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Núñez",
                                    "ce:indexed-name": "Nunez M."
                                }
                            ]},
                            "ref-sourcetitle": "JIAPAC."
                        },
                        "ce:source-text": "Huang AJ, Núñez M,. Outcomes in HIV/HBV-coinfected patients in the tenofovir era are greatly affected by immune suppression. JIAPAC. 2015; 14: 360-368."
                    },
                    {
                        "ref-fulltext": "Jaroszewicz J, Reiberger T, Meyer-Olson D, et al. Hepatitis B surface antigen concentrations in patients with HIV/HBV Co-infection. PLoS One. 2012; 7: E43143.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Hepatitis B surface antigen concentrations in patients with HIV/HBV Co-infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865048824",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "43143"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jaroszewicz",
                                        "ce:indexed-name": "Jaroszewicz J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Reiberger",
                                        "ce:indexed-name": "Reiberger T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Meyer-Olson",
                                        "ce:indexed-name": "Meyer-Olson D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One."
                        },
                        "ce:source-text": "Jaroszewicz J, Reiberger T, Meyer-Olson D, et al. Hepatitis B surface antigen concentrations in patients with HIV/HBV Co-infection. PLoS One. 2012; 7: E43143."
                    },
                    {
                        "ref-fulltext": "Kosi L, Reiberger T, Payer BA, et al. Five-year on-Treatment efficacy of lamivudine-, tenofovir-And tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients. J Viral Hepat. 2012; 19: 801-810.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Five-year on-Treatment efficacy of lamivudine-, tenofovir-And tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867399642",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "801",
                                    "@last": "810"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Kosi",
                                        "ce:indexed-name": "Kosi L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Reiberger",
                                        "ce:indexed-name": "Reiberger T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Payer",
                                        "ce:indexed-name": "Payer B.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Viral Hepat."
                        },
                        "ce:source-text": "Kosi L, Reiberger T, Payer BA, et al. Five-year on-Treatment efficacy of lamivudine-, tenofovir-And tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients. J Viral Hepat. 2012; 19: 801-810."
                    },
                    {
                        "ref-fulltext": "Maylin S, Boyd A, Lavocat F, et al. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients. AIDS. 2012; 26: 939-949.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84861098339",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "939",
                                    "@last": "949"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Maylin",
                                        "ce:indexed-name": "Maylin S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Boyd",
                                        "ce:indexed-name": "Boyd A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Lavocat",
                                        "ce:indexed-name": "Lavocat F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Maylin S, Boyd A, Lavocat F, et al. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients. AIDS. 2012; 26: 939-949."
                    },
                    {
                        "ref-fulltext": "Miailhes P, Trabaud M-A, Pradat P, et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: Relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis. 2007; 45: 624-632.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: Relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34548243711",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "624",
                                    "@last": "632"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Miailhes",
                                        "ce:indexed-name": "Miailhes P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.-A.",
                                        "@_fa": "true",
                                        "ce:surname": "Trabaud",
                                        "ce:indexed-name": "Trabaud M.-A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Pradat",
                                        "ce:indexed-name": "Pradat P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis."
                        },
                        "ce:source-text": "Miailhes P, Trabaud M-A, Pradat P, et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: Relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis. 2007; 45: 624-632."
                    },
                    {
                        "ref-fulltext": "Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, et al. Hepatitis B surface antigen declines and clearance during long-Term tenofovir therapy in patients coinfected with HBV and HIV. J Infect Dis. 2012; 206: 974-980.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Hepatitis B surface antigen declines and clearance during long-Term tenofovir therapy in patients coinfected with HBV and HIV"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865772501",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "206"},
                                "pagerange": {
                                    "@first": "974",
                                    "@last": "980"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Zoutendijk",
                                        "ce:indexed-name": "Zoutendijk R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Zaaijer",
                                        "ce:indexed-name": "Zaaijer H.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.E.",
                                        "@_fa": "true",
                                        "ce:surname": "De Vries-Sluijs",
                                        "ce:indexed-name": "De Vries-Sluijs T.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis."
                        },
                        "ce:source-text": "Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, et al. Hepatitis B surface antigen declines and clearance during long-Term tenofovir therapy in patients coinfected with HBV and HIV. J Infect Dis. 2012; 206: 974-980."
                    },
                    {
                        "ref-fulltext": "Moore RD, Keruly JC,. CD4+ cell count 6 Years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007; 44: 441-446.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "CD4+ cell count 6 Years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33846439783",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "441",
                                    "@last": "446"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Moore",
                                    "ce:indexed-name": "Moore R.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Keruly",
                                    "ce:indexed-name": "Keruly J.C."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Infect Dis."
                        },
                        "ce:source-text": "Moore RD, Keruly JC,. CD4+ cell count 6 Years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007; 44: 441-446."
                    },
                    {
                        "ref-fulltext": "Stirrup OT, Copas AJ, Phillips AN, et al. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Med. 2018; 19: 184-194.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85036520954",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "184",
                                    "@last": "194"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Stirrup",
                                        "ce:indexed-name": "Stirrup O.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Copas",
                                        "ce:indexed-name": "Copas A.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Phillips",
                                        "ce:indexed-name": "Phillips A.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "HIV Med."
                        },
                        "ce:source-text": "Stirrup OT, Copas AJ, Phillips AN, et al. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Med. 2018; 19: 184-194."
                    },
                    {
                        "ref-fulltext": "Buti M, Tsai N, Petersen J, et al. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection. Dig Dis Sci. 2015; 60: 1457-1464.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84939650468",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "1457",
                                    "@last": "1464"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Buti",
                                        "ce:indexed-name": "Buti M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Petersen",
                                        "ce:indexed-name": "Petersen J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Dis Sci."
                        },
                        "ce:source-text": "Buti M, Tsai N, Petersen J, et al. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection. Dig Dis Sci. 2015; 60: 1457-1464."
                    },
                    {
                        "ref-fulltext": "Strassl R, Reiberger T, Honsig C, et al. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients. J Viral Hepat. 2014; 21: 508-16.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84902285405",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "508",
                                    "@last": "516"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Strassl",
                                        "ce:indexed-name": "Strassl R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Reiberger",
                                        "ce:indexed-name": "Reiberger T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Honsig",
                                        "ce:indexed-name": "Honsig C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Viral Hepat."
                        },
                        "ce:source-text": "Strassl R, Reiberger T, Honsig C, et al. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients. J Viral Hepat. 2014; 21: 508-16."
                    },
                    {
                        "ref-fulltext": "Casetti R, Pinnetti C, Sacchi A, et al. HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection. JAIDS. 2017; 75: 338-344.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017619469",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "75"},
                                "pagerange": {
                                    "@first": "338",
                                    "@last": "344"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Casetti",
                                        "ce:indexed-name": "Casetti R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Pinnetti",
                                        "ce:indexed-name": "Pinnetti C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sacchi",
                                        "ce:indexed-name": "Sacchi A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAIDS."
                        },
                        "ce:source-text": "Casetti R, Pinnetti C, Sacchi A, et al. HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection. JAIDS. 2017; 75: 338-344."
                    },
                    {
                        "ref-fulltext": "Hua W, Jiao Y, Zhang H, et al. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment. Immunol Invest. 2012; 41: 1-14.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "81555218168",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "14"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Hua",
                                        "ce:indexed-name": "Hua W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Jiao",
                                        "ce:indexed-name": "Jiao Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Immunol Invest."
                        },
                        "ce:source-text": "Hua W, Jiao Y, Zhang H, et al. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment. Immunol Invest. 2012; 41: 1-14."
                    },
                    {
                        "ref-fulltext": "Lu X, Su B, Xia H, et al. Low double-negative CD3(+)CD4(-)CD8(-) T cells are associated with incomplete restoration of CD4(+) T cells and higher immune activation in HIV-1 immunological non-responders. Front Immunol. 2016; 7: 579.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Low double-negative CD3(+)CD4(-)CD8(-) T cells are associated with incomplete restoration of CD4(+) T cells and higher immune activation in HIV-1 immunological non-responders"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85009398235",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "579"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Su",
                                        "ce:indexed-name": "Su B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Xia",
                                        "ce:indexed-name": "Xia H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol."
                        },
                        "ce:source-text": "Lu X, Su B, Xia H, et al. Low double-negative CD3(+)CD4(-)CD8(-) T cells are associated with incomplete restoration of CD4(+) T cells and higher immune activation in HIV-1 immunological non-responders. Front Immunol. 2016; 7: 579."
                    },
                    {
                        "ref-fulltext": "Soriano V, Puoti M, Bonacini M, et al. Care of patients with chronic hepatitis B and HIV co-infection: Recommendations from an HIV-HBV international panel. AIDS. 2005; 19: 221-240.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Care of patients with chronic hepatitis B and HIV co-infection: Recommendations from an HIV-HBV international panel"},
                            "refd-itemidlist": {"itemid": {
                                "$": "15444376498",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "221",
                                    "@last": "240"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Soriano",
                                        "ce:indexed-name": "Soriano V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Puoti",
                                        "ce:indexed-name": "Puoti M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonacini",
                                        "ce:indexed-name": "Bonacini M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Soriano V, Puoti M, Bonacini M, et al. Care of patients with chronic hepatitis B and HIV co-infection: Recommendations from an HIV-HBV international panel. AIDS. 2005; 19: 221-240."
                    },
                    {
                        "ref-fulltext": "Matthews GV, Seaberg E, Dore GJ, et al. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS. 2009; 23: 1707-1715.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals"},
                            "refd-itemidlist": {"itemid": {
                                "$": "69449101509",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "1707",
                                    "@last": "1715"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Matthews",
                                        "ce:indexed-name": "Matthews G.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Seaberg",
                                        "ce:indexed-name": "Seaberg E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Dore",
                                        "ce:indexed-name": "Dore G.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Matthews GV, Seaberg E, Dore GJ, et al. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS. 2009; 23: 1707-1715."
                    },
                    {
                        "ref-fulltext": "Boyd A, Maylin S, Gozlan J, et al. Use of hepatitis B surface and \"e\" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV. Liver Int. 2015; 35: 795-804.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Use of hepatitis B surface and \"e\" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84922700012",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "795",
                                    "@last": "804"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Boyd",
                                        "ce:indexed-name": "Boyd A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Maylin",
                                        "ce:indexed-name": "Maylin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gozlan",
                                        "ce:indexed-name": "Gozlan J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Liver Int."
                        },
                        "ce:source-text": "Boyd A, Maylin S, Gozlan J, et al. Use of hepatitis B surface and \"e\" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV. Liver Int. 2015; 35: 795-804."
                    },
                    {
                        "ref-fulltext": "Kang M, Hollabaugh K, Pham V, et al. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. JAIDS. 2014; 66: 172-180.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84901482067",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "172",
                                    "@last": "180"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hollabaugh",
                                        "ce:indexed-name": "Hollabaugh K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Pham",
                                        "ce:indexed-name": "Pham V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAIDS."
                        },
                        "ce:source-text": "Kang M, Hollabaugh K, Pham V, et al. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. JAIDS. 2014; 66: 172-180."
                    },
                    {
                        "ref-fulltext": "Martin-Carbonero L, Teixeira T, Poveda E, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-Term nucleos(t)ide analogues. AIDS. 2011; 25: 73-79.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-Term nucleos(t)ide analogues"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78650307553",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "73",
                                    "@last": "79"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin-Carbonero",
                                        "ce:indexed-name": "Martin-Carbonero L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Teixeira",
                                        "ce:indexed-name": "Teixeira T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Poveda",
                                        "ce:indexed-name": "Poveda E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Martin-Carbonero L, Teixeira T, Poveda E, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-Term nucleos(t)ide analogues. AIDS. 2011; 25: 73-79."
                    },
                    {
                        "ref-fulltext": "Gilson RJ, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS. 1997; 11: 597-606.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "8044229048",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "597",
                                    "@last": "606"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gilson",
                                        "ce:indexed-name": "Gilson R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hawkins",
                                        "ce:indexed-name": "Hawkins A.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Beecham",
                                        "ce:indexed-name": "Beecham M.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS."
                        },
                        "ce:source-text": "Gilson RJ, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS. 1997; 11: 597-606."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Melbourne",
            "@id": "60005245",
            "affilname": "Royal Melbourne Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005245",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60025702",
            "affilname": "St. Vincent's Hospital Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025702",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60023619",
            "affilname": "Melbourne Sexual Health Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023619",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60019578",
            "affilname": "Monash University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Clayton",
            "@id": "60012932",
            "affilname": "Faculty of Medicine, Nursing and Health Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012932",
            "affiliation-country": "Australia"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85088610614",
        "dc:description": "Background:Tenofovir disoproxil fumarate (TDF) is effective in suppressing HIV and hepatitis B virus (HBV) replication in HIV-HBV coinfection although HBV DNA can persist in some individuals on TDF-containing antiretroviral therapy (ART). We initiated a prospective longitudinal study to determine durability of HBV virological control and clinical outcomes after prolonged TDF-based ART in HIV-HBV coinfection.Methods:Ninety-two HIV-HBV coinfected participants on, or about to commence, TDF-containing ART from Australia (n = 41) and Thailand (n = 52) were enrolled. Participants were followed 6-monthly for 2 years, then annually to 5 years. Laboratory and clinical assessments and a serum sample were collected at each study visit. These analyses compare follow-up at 2 and 5 years.Results:12.0% (95% confidence interval 6.8 to 20.2) of total study entry cohort (n = 92) or 15.3% (95% confidence interval: 8.8 to 25.3) of those with data to year 5 (n = 72) lost hepatitis B surface antigen (HBsAg). The only statistically significant association with HBsAg loss was lower study entry quantitative HBsAg. CD4 T-cell count increased by a median 245 cells/mm3 between the preTDF sample and 5 years of follow-up. By year 5, 98.5% of the cohort had undetectable HBV DNA (<15 IU/mL) and 91.4% had undetectable HIV RNA (<20 copies/mL).Conclusions:HBsAg loss was high and ongoing over 5 years of follow-up in HIV-HBV coinfected individuals on TDF-containing ART and undetectable HBV was almost universal. Although the pattern of HBsAg loss temporarily parallels immune reconstitution, we could not identify predictive immune markers. The high rate of HBsAg loss in HIV-HBV coinfection may offer valuable insights into the search for a functional HBV cure.",
        "pubmed-id": "32692112",
        "prism:coverDate": "2020-08-15",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85088610614",
        "dc:creator": {"author": [{
            "ce:given-name": "Jennifer",
            "preferred-name": {
                "ce:given-name": "Jennifer",
                "ce:initials": "J.",
                "ce:surname": "Audsley",
                "ce:indexed-name": "Audsley J."
            },
            "@seq": "1",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60026553",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553"
                },
                {
                    "@id": "60019578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578"
                }
            ],
            "ce:degrees": "PhD",
            "ce:surname": "Audsley",
            "@auid": "6508214967",
            "author-url": "https://api.elsevier.com/content/author/author_id/6508214967",
            "ce:indexed-name": "Audsley J."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85088610614"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088610614&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85088610614&origin=inward"
            }
        ],
        "source-id": "15300154823",
        "citedby-count": "12",
        "prism:volume": "84",
        "subtype": "ar",
        "dc:title": "Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?",
        "openaccess": "0",
        "prism:issn": "10779450 15254135",
        "publishercopyright": "© 2020 Wolters Kluwer Health, Inc.",
        "prism:issueIdentifier": "5",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Acquired Immune Deficiency Syndromes",
        "prism:pageRange": "527-533",
        "prism:endingPage": "533",
        "openaccessFlag": "false",
        "prism:doi": "10.1097/QAI.0000000000002386",
        "prism:startingPage": "527",
        "dc:identifier": "SCOPUS_ID:85088610614",
        "dc:publisher": "Lippincott Williams and Wilkins"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Anti-HIV Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Australia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Coinfection",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "DNA, Viral",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Administration Schedule",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B Surface Antigens",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B, Chronic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV-1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "RNA, Viral",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tenofovir",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "HBsAg seroloss"
        },
        {
            "@_fa": "true",
            "$": "HBV"
        },
        {
            "@_fa": "true",
            "$": "HIV"
        },
        {
            "@_fa": "true",
            "$": "long-term ART"
        },
        {
            "@_fa": "true",
            "$": "tenofovir"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Jennifer",
            "preferred-name": {
                "ce:given-name": "Jennifer",
                "ce:initials": "J.",
                "ce:surname": "Audsley",
                "ce:indexed-name": "Audsley J."
            },
            "@seq": "1",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60026553",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553"
                },
                {
                    "@id": "60019578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578"
                }
            ],
            "ce:degrees": "PhD",
            "ce:surname": "Audsley",
            "@auid": "6508214967",
            "author-url": "https://api.elsevier.com/content/author/author_id/6508214967",
            "ce:indexed-name": "Audsley J."
        },
        {
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD PhD",
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        },
        {
            "ce:given-name": "Margaret",
            "preferred-name": {
                "ce:given-name": "Margaret",
                "ce:initials": "M.",
                "ce:surname": "Littlejohn",
                "ce:indexed-name": "Littlejohn M."
            },
            "@seq": "3",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005245",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005245"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Littlejohn",
            "@auid": "16233499900",
            "author-url": "https://api.elsevier.com/content/author/author_id/16233499900",
            "ce:indexed-name": "Littlejohn M."
        },
        {
            "ce:given-name": "Scott",
            "preferred-name": {
                "ce:given-name": "Scott",
                "ce:initials": "S.",
                "ce:surname": "Bowden",
                "ce:indexed-name": "Bowden S."
            },
            "@seq": "4",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005245",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005245"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Bowden",
            "@auid": "56225356200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56225356200",
            "ce:indexed-name": "Bowden S."
        },
        {
            "ce:given-name": "Gail V.",
            "preferred-name": {
                "ce:given-name": "Gail V.",
                "ce:initials": "G.V.",
                "ce:surname": "Matthews",
                "ce:indexed-name": "Matthews G.V."
            },
            "@seq": "5",
            "ce:initials": "G.V.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60026655",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"
                },
                {
                    "@id": "60025702",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025702"
                }
            ],
            "ce:degrees": "MD PhD",
            "ce:surname": "Matthews",
            "@auid": "7201421490",
            "author-url": "https://api.elsevier.com/content/author/author_id/7201421490",
            "ce:indexed-name": "Matthews G.V."
        },
        {
            "ce:given-name": "Christopher K.",
            "preferred-name": {
                "ce:given-name": "Christopher K.",
                "ce:initials": "C.K.",
                "ce:surname": "Fairley",
                "ce:indexed-name": "Fairley C.K."
            },
            "@seq": "6",
            "ce:initials": "C.K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60023619",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023619"
                },
                {
                    "@id": "60012932",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012932"
                }
            ],
            "ce:degrees": "MD PhD",
            "ce:surname": "Fairley",
            "@auid": "55382768300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55382768300",
            "ce:indexed-name": "Fairley C.K."
        },
        {
            "ce:given-name": "Sharon R.",
            "preferred-name": {
                "ce:given-name": "Sharon R.",
                "ce:initials": "S.R.",
                "ce:surname": "Lewin",
                "ce:indexed-name": "Lewin S.R."
            },
            "@seq": "7",
            "ce:initials": "S.R.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60026553",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553"
                },
                {
                    "@id": "60019578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578"
                }
            ],
            "ce:degrees": "MD PhD",
            "ce:surname": "Lewin",
            "@auid": "15737239300",
            "author-url": "https://api.elsevier.com/content/author/author_id/15737239300",
            "ce:indexed-name": "Lewin S.R."
        },
        {
            "ce:given-name": "Joe",
            "preferred-name": {
                "ce:given-name": "Joe",
                "ce:initials": "J.",
                "ce:surname": "Sasadeusz",
                "ce:indexed-name": "Sasadeusz J."
            },
            "@seq": "8",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60019578",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578"
                },
                {
                    "@id": "60005245",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005245"
                }
            ],
            "ce:degrees": "MD PhD",
            "ce:surname": "Sasadeusz",
            "@auid": "6701322695",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701322695",
            "ce:indexed-name": "Sasadeusz J."
        }
    ]}
}}